About Us

The IQVIA team in the Middle East works to provide clarity in such a dynamic market. Our vast experience, local team of healthcare professionals, and global pool of resources, give us the knowledge and understanding to help clients navigate through the local cultural and regulatory nuances, and respond to new market realities quickly, effectively, and with more precision.

We help our clients predict future trends, minimize risks, and understand the local market better. Our information, analytics, technology solutions, and consulting expertise empower them with tools and real-world evidence that grant in-depth insights to make better informed decisions.

The Middle Eastern healthcare and pharmaceutical markets are in an ongoing state of innovative transformation. While spending has started to saturate the market, trends such as compulsory health insurance schemes and medical tourism push players across the ecosystem to reflexively adopt the latest advancements, connect with each other, and optimize existing resources.

Learn more about IQVIA

Webinar
Let’s Talk Oncology: Pharma in the Middle East

April 10 at 11:30

Contact Us

Egypt
Building S2B, Downtown Kattameya
Road 90, 5th Settlement
New Cairo, Egypt

Kuwait
QuintilesIMS, KIPCO Tower, 27th Floor
Block 9, Al Shuhadaa St, Sharq
P.O Box 25363
Safat 13114
Kuwait

Lebanon
Sin El Fil, Beirut Hall Area
Next to Square Center
Getaway Center, 2nd floor
Beirut, Lebanon

Palestinian Territory
1st Floor 
Ccc House Ramallah 
Ersal Center, Ramallah 
West Bank, Palestine

UAE
Convention Tower, 11th Floor
DWTC
Al Saada Street
Dubai
United Arab Emirates

+971 4 567 17 00

Osteoporosis in the Kingdom Of Saudi Arabia

Epidemiology and Associated Economic Costs
Worldwide, the prevalence of osteoporosis, and hence the incidence of related fractures, is high, especially due to aging populations. Osteoporotic fractures frequently require inpatient care.
 

Oncology in the Middle East Market

Continued Growth Expected
The global oncology market is expected to continue growing at 9% between 2016 and 2021, one of the highest forecasted growth rates. The focus on oncology will remain high over the next decade as pharma companies continue to invest resources and efforts.

Middle East and Africa Pharmaceutical Market

Quarterly Insights Report
The seventh edition of our quarterly market report covers a broad region from Middle East, North Africa, French West Africa and South Africa for the period of MAT Q3 2013 to MAT Q3 2017. This report will provide you with an overview of the market dynamics in terms of size, growth, therapy area and competitive landscape.